Norms of international law in the field of application of the results of scientific research in the field of biotechnology (on the example of therapeutic and reproductive cloning and editing of the human genome) and their patent protection

Maryam Abdurakhmanovna Akhmadova
DOI: https://doi.org/10.7256/2454-0633.2024.3.33231
2024-03-01
Международное право и международные организации / International Law and International Organizations
Abstract:The article is aimed at covering a number of issues in the field of legal regulation of innovative medical technologies based on intervention in the human genome and cloning (therapeutic and reproductive) in the context of the provisions of international law (conventions, declarations, bilateral agreements). In this format, the author examines some international acts that have created a legal paradigm for regulating scientific research in the area under study, defining the boundaries of admissibility of the introduction of the designated achievements of modern science in clinical medicine, which are designed to act as an effective tool in the fight against severe hereditary diseases, etc., which potentially predetermines their demand. The author focuses on the issue of patentability of these biotechnologies. The study used such methods of scientific knowledge as: general scientific dialectical, formal-legal and comparative-legal methods. At the same time, the author proceeds from the subjective-objective nature of processes and phenomena, and their interconnectedness. The novelty of the study is determined by its purpose, subject and range of sources considered. Thus, the author examines the provisions of both regulatory acts and soft law acts, emphasizing the peculiarities of the legal nature of both. In this format, the author formulates the conclusion that the system of international principles and standards formed by the considered acts and documents does not contain an explicit permission to carry out scientific research in the considered field of biotechnology with subsequent commercialization of the results that can be patented as inventions, which leads to the need to create a national legal foundation by modern states wishing to advance in this area, mandatory for execution, as a result of which the legal map of the world acquires a rather mosaic character, when innovative biotechnologies are distributed in countries with legislation loyal to scientific research, which are, in fact, "scientific offshores".
What problem does this paper attempt to address?